Question · asked by 1 review

Prednisone (oral, commencing 25 mg with phased dose reduction over 2 months) vs placebo: Days to resolution of pain / epithelialization; number of aphthae per month

What each review found

Current versions only
FindingEffectStudiesGRADE certainty
Prednisone (oral, commencing 25 mg with phased dose reduction over 2 months) vs Placebo
Days to resolution of pain and epithelialization of aphthae; number of aphthae per month · Participants with a previous or current history of recurrent aphthous stomatitis (RAS), diagnosed on history and… · 2 months
Systemic interventions for recurrent aphthous stomatitis (mouth ulcers) (2012) · Cochrane All outcomes
Femiano 2003 (high risk of bias) reports days to resolution of pain and days to epithelialization of aphthae at 1 month, and number of aphthae per month after the first and second months; data presented as…1 study · 20 participantsGRADE not reported

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Systemic interventions for recurrent aphthous stomatitis (mouth ulcers)
2012 · Cochrane All outcomes
2012-06list not extracted yetNot assessed

Studies behind the findings

None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.